Safety Profile

NeuroStar TMS Therapy® has a proven safety profile

NeuroStar TMS Therapy is safe and easy to tolerate. Because it is not a drug that circulates throughout the body, NeuroStar TMS Therapy does not cause the side effects that patients often experience from antidepressant medications.

Safety Profile

NeuroStar TMS Therapy is free of systemic side effects such as5,6:

Common Side Effects from Drug Therapy*

  • Abnormal ejaculation
  • Decreased libido
  • Diarrhea
  • Daytime drowsiness
  • Nervousness
  • Increased weight
  • Decreased appetite
  • Dry mouth
  • Fatigue
  • Sweating
  • Treatment discontinuation side effects
  • Impotence
  • Constipation
  • Nausea
  • Insomnia
  • Anxiety
  • Increased appetite
  • Weakness
  • Dizziness
  • Headache/migraine
  • Tremor

Abnormal ejaculation
Decreased libido
Diarrhea
Daytime drowsiness
Nervousness
Increased weight
Decreased appetite
Dry mouth
Fatigue
Sweating
Treatment discontinuation side effects
Impotence
Constipation
Nausea
Insomnia
Anxiety
Increased appetite
Weakness
Dizziness
Headache/migraine
Tremor

NeuroStar TMS Therapy Side Effects

In clinical trials, fewer than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to adverse events. The most common side effect associated with NeuroStar TMS Therapy is temporary pain or discomfort at or near the treatment site during treatment. When this occurs it is temporary, and typically occurs only during the first week of treatment. Other side effects include eye pain, toothache, muscle twitch, facial pain and pain of the skin (occurring in ≥5% of patients and at 2 times the rate of placebo). There is a rare risk of seizure with TMS therapy (0.1% of patients).1,5

Patients should notify their doctor if they experience worsening depression symptoms, signs or symptoms of suicidal behavior and/or unusual behavior. Family members and support individuals should also be aware of the need to observe patients and notify their treatment provider if symptoms worsen.1

NeuroStar TMS Therapy should not be used with patients who have non-removable conductive metal or stimulator implants in or near the head.1

* From product labeling for currently marketed antidepressant medications;
adverse events occurring at an incidence of >5% and 2 times the rate of placebo treatment.6

Worldwide Distributors

Find a NeuroStar TMS Therapy distributor in your country.